C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | -96.0% | 320 | -95.9% | 0.00% | – |
| Q1 2023 | $25 | -85.2% | 7,864 | -72.5% | 0.00% | – |
| Q4 2022 | $169 | -99.9% | 28,602 | +0.1% | 0.00% | – |
| Q3 2022 | $251,000 | +16.7% | 28,577 | +0.4% | 0.00% | – |
| Q2 2022 | $215,000 | -68.9% | 28,452 | -0.3% | 0.00% | -100.0% |
| Q1 2022 | $692,000 | -24.6% | 28,541 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $918,000 | -17.7% | 28,523 | +14.3% | 0.00% | 0.0% |
| Q3 2021 | $1,115,000 | -0.4% | 24,955 | -15.6% | 0.00% | 0.0% |
| Q2 2021 | $1,119,000 | +221.6% | 29,581 | +214.7% | 0.00% | – |
| Q1 2021 | $348,000 | +34.9% | 9,400 | +20.5% | 0.00% | – |
| Q4 2020 | $258,000 | – | 7,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |